186 related articles for article (PubMed ID: 20849483)
1. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy.
Karaahmet T; Tigen K; Dundar C; Pala S; Guler A; Kilicgedik A; Cevik C; Mahmutyazicioglu K; Isiklar I; Basaran Y
Echocardiography; 2010 Sep; 27(8):954-60. PubMed ID: 20849483
[TBL] [Abstract][Full Text] [Related]
2. Relation of replacement fibrosis to left ventricular diastolic function in patients with dilated cardiomyopathy.
Malaty AN; Shah DJ; Abdelkarim AR; Nagueh SF
J Am Soc Echocardiogr; 2011 Mar; 24(3):333-8. PubMed ID: 21338867
[TBL] [Abstract][Full Text] [Related]
3. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
Fried I; Bar-Oz B; Algur N; Fried E; Gavri S; Yatsiv I; Perles Z; Rein AJ; Zonis Z; Bass R; Nir A
Pediatrics; 2006 Oct; 118(4):e1165-8. PubMed ID: 16966393
[TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy.
Demachi J; Kagaya Y; Watanabe J; Sakuma M; Ikeda J; Kakuta Y; Motoyoshi I; Kohnosu T; Sakuma H; Shimazaki S; Sakai H; Kimpara T; Takahashi T; Omura K; Okada M; Saito H; Shirato K
Neuromuscul Disord; 2004 Nov; 14(11):732-9. PubMed ID: 15482958
[TBL] [Abstract][Full Text] [Related]
6. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
7. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
8. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy.
Henkel DM; Glockner J; Miller WL
Am J Cardiol; 2012 Feb; 109(3):390-4. PubMed ID: 22078219
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
10. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.
Limongelli G; Pacileo G; Ancona R; Eusebio G; D'Andrea A; Romano M; Di Salvo G; Rea A; Calabró P; Romano G; Maiello C; Calabró R
Am J Cardiol; 2010 Mar; 105(5):716-20. PubMed ID: 20185022
[TBL] [Abstract][Full Text] [Related]
13. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
[TBL] [Abstract][Full Text] [Related]
15. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
17. Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.
Alter P; Rupp H; Rominger MB; Vollrath A; Czerny F; Klose KJ; Maisch B
Can J Physiol Pharmacol; 2007 Aug; 85(8):790-9. PubMed ID: 17901889
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels.
Babür Güler G; Karaahmet T; Tigen K
Anadolu Kardiyol Derg; 2011 Feb; 11(1):71-6. PubMed ID: 21220243
[TBL] [Abstract][Full Text] [Related]
19. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
[TBL] [Abstract][Full Text] [Related]
20. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
